IDEAYA Biosciences Inc (IDYA)
29.58
-0.42
(-1.42%)
USD |
NASDAQ |
Nov 05, 16:00
29.58
0.00 (0.00%)
After-Hours: 18:51
IDEAYA Biosciences Enterprise Value: 1.833B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.833B |
| November 01, 2024 | 1.715B |
| October 31, 2024 | 1.676B |
| October 30, 2024 | 1.787B |
| October 29, 2024 | 1.821B |
| October 28, 2024 | 1.834B |
| October 25, 2024 | 1.774B |
| October 24, 2024 | 1.765B |
| October 23, 2024 | 1.791B |
| October 22, 2024 | 1.851B |
| October 21, 2024 | 1.907B |
| October 18, 2024 | 1.878B |
| October 17, 2024 | 1.891B |
| October 16, 2024 | 1.917B |
| October 15, 2024 | 1.902B |
| October 14, 2024 | 1.872B |
| October 11, 2024 | 1.909B |
| October 10, 2024 | 1.850B |
| October 09, 2024 | 1.789B |
| October 08, 2024 | 1.922B |
| October 07, 2024 | 1.783B |
| October 04, 2024 | 1.830B |
| October 03, 2024 | 1.769B |
| October 02, 2024 | 1.976B |
| October 01, 2024 | 1.894B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.975B |
| September 27, 2024 | 1.900B |
| September 26, 2024 | 1.875B |
| September 25, 2024 | 1.864B |
| September 24, 2024 | 1.949B |
| September 23, 2024 | 2.148B |
| September 20, 2024 | 2.255B |
| September 19, 2024 | 2.279B |
| September 18, 2024 | 2.234B |
| September 17, 2024 | 2.321B |
| September 16, 2024 | 2.410B |
| September 13, 2024 | 2.463B |
| September 12, 2024 | 2.349B |
| September 11, 2024 | 2.357B |
| September 10, 2024 | 2.394B |
| September 09, 2024 | 2.378B |
| September 06, 2024 | 2.357B |
| September 05, 2024 | 2.455B |
| September 04, 2024 | 2.550B |
| September 03, 2024 | 2.518B |
| August 30, 2024 | 2.635B |
| August 29, 2024 | 2.607B |
| August 28, 2024 | 2.643B |
| August 27, 2024 | 2.623B |
| August 26, 2024 | 2.661B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-37.31M
Minimum
Mar 17 2020
2.989B
Maximum
Feb 16 2024
762.00M
Average
420.95M
Median
Jun 14 2021
Enterprise Value Benchmarks
| Black Diamond Therapeutics Inc | 45.98M |
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -52.77M |
| Total Expenses (Quarterly) | 64.93M |
| EPS Diluted (Quarterly) | -0.68 |
| Earnings Yield | -7.40% |
| Normalized Earnings Yield | -6.764 |